eMolecules
Business Intelligence (BI) Software · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3430 Carmel Mountain Rd Ste 250, San Die...Phone Number
(858) 764-1941Website
www.emolecules.comRevenue
$32.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
2
1
About eMolecules
eMolecules is driven to improve the human condition by enabling scientists to accelerate their research to find effective therapeutics. To achieve this, eMolecules provides business intelligence data and integrated ecommerce software for screening compound, chemical building blocks and primary antibody supply chains. These tools, combined with their acquisition, aggregation and analytical services, greatly empower drug discovery researchers working in the pharmaceutical, biotechnology, academia, CRO and agrochemical industries. A privately owned company, eMolecules was founded in 2005 at its San Diego headquarters and has offices in Boston and London , employing over 50 people across the three sites.Explore more
eMolecules Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is eMolecules your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at eMolecules
Click to see if eMolecules had a recent Job posting/layoffs
Funding: Get notified immidiatlly once eMolecules has new funding data
Product Launch: Get notified when eMolecules launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if eMolecules is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on eMolecules recently announced quarterly report
Check if eMolecules has recently received funding, and reach out quickly before it becomes old news!
eMolecules, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined eMolecules as Masked Content
Find 3 more new buyers
Compare Similar Companies to eMolecules
Compare insights from companies similar to eMolecules, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
eMolecules is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
eMolecules is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about eMolecules.
eMolecules financials insights
Gather financial insights about eMolecules, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
eMolecules Tech Stack
A closer look at the technologies used by eMolecules
Most Recent Scoops
Hiring Plans
eMolecules has more open roles in Finance than it has had at any time in the past 12 months.
Hiring Plans
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
eMolecules News & Media
eMolecules Acquires Synple Chem AG
Combination strengthens eMolecules' position as the global one-stop-shop solution provider for efficient chemical compound procurement, full-service compound management and automation solutions for drug discovery researchers SAN DIEGO and ZURICH, Sept. 24, 2024 /PRNewswire/ -- eMolecules,...eMolecules acquires Specs Compound Handling B.V.
Combination expands footprint offering a global one-stop shop for streamlined chemical compound procurement and management services for drug discovery chemistry researchers. SAN DIEGO and ZOETERMEER, The Netherlands, May 25, 2023 /PRNewswire/ -- eMolecules, Inc., an industry leading...eMolecules acquires Frontier Scientific Inc. and Frontier Agricultural Sciences Inc.
Combination establishes a one-stop shop for efficient end-to-end solutions that facilitate chemical compound procurement and management for highly specialized chemists SAN DIEGO and NEWARK, Del., Sept. 7, 2022 /PRNewswire/ -- eMolecules, Inc., provider of a leading chemistry...Avista Capital invests in eMolecules
Avista Capital invests in eMolecules Submitted 25/03/2021 - 2:50pm Avista Capital Partners (Avista), a private equity firm focused exclusively on healthcare, is to invest in eMolecules, a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by pharmaceutical companies in drug discovery. Financial terms of the investment have not been disclosed. Founded in 2005, eMolecules accelerates the drug discovery process by connecting pharmaceutical and biotechnology
Read more news
Top Business Intelligence (BI) Software Companies
See more top companies
Frequently Asked Questions Regarding eMolecules
Sign Up For FreeTo access detailed company insights
eMolecules is driven to improve the human condition by enabling scientists to accelerate their research to find effective therapeutics. To achieve this, eMolecules provides business intelligence data and integrated ecommerce software for screening compound, chemical building blocks and primary antibody supply chains. These tools, combined with thei... Read More
